198 related articles for article (PubMed ID: 37397643)
1. Hepatitis C Cirrhosis, Hepatitis B Superimposed Infection, and the Emergence of an Acute Portal Vein Thrombosis: A Case Report.
Kasmikha L; Khan N; Almajed MR; Entz A; Jafri SM
Cureus; 2023 Jun; 15(6):e39839. PubMed ID: 37397643
[TBL] [Abstract][Full Text] [Related]
2. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
[TBL] [Abstract][Full Text] [Related]
3. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis.
Lertpipopmetha K; Auewarakul CU
BMC Gastroenterol; 2011 Jun; 11():66. PubMed ID: 21658275
[TBL] [Abstract][Full Text] [Related]
4. Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response.
Mandorfer M; Turon F; Lens S; Baiges A; García-Criado Á; Darnell A; Belmonte E; Ferrusquía-Acosta J; Magaz M; Perez-Campuzano V; Olivas P; Bauer D; Casanovas G; Torres F; Mariño Z; Forns X; Hernández-Gea V; García-Pagán JC
Liver Int; 2021 Dec; 41(12):2954-2964. PubMed ID: 34242479
[TBL] [Abstract][Full Text] [Related]
5. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.
Wang T; Tan W; Wang X; Zheng X; Huang Y; Li B; Meng Z; Gao Y; Qian Z; Liu F; Lu X; Yan H; Zheng Y; Zhang W; Yin S; Gu W; Zhang Y; Dong F; Wei J; Deng G; Xiang X; Zhou Y; Hou Y; Zhang Q; Xiong S; Liu J; Long L; Chen R; Chen J; Jiang X; Luo S; Chen Y; Jiang C; Zhao J; Ji L; Mei X; Li J; Li T; Zheng R; Zhou X; Ren H; Shi Y; Li H;
JHEP Rep; 2022 Oct; 4(10):100529. PubMed ID: 36052222
[TBL] [Abstract][Full Text] [Related]
6. Management of Chronic Portal Vein Thrombosis in a Cirrhotic Patient With Pancytopenia and Grade II Esophageal Varices.
Aziz AA; Yang D; Naeem M; Christmas D
Cureus; 2022 Jan; 14(1):e21150. PubMed ID: 35165600
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.
Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319
[TBL] [Abstract][Full Text] [Related]
8. Portal Vein Thrombosis in Patients With Cirrhosis of the Liver: Prevalence and Risk Factors.
Koumar L; Senthamizhselvan K; Barathi D; Verma A; Rao P; Selvaraj J; Sanker V
Cureus; 2023 Dec; 15(12):e50134. PubMed ID: 38186444
[TBL] [Abstract][Full Text] [Related]
9. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.
Rugivarodom M; Charatcharoenwitthaya P
J Clin Transl Hepatol; 2020 Dec; 8(4):432-444. PubMed ID: 33447527
[TBL] [Abstract][Full Text] [Related]
10. [Construction and validation of a nomogram for predicting the risk of portal vein thrombosis after splenectomy in patients with hepatitis B cirrhosis].
Xu W; Cheng Y; Tu B
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1265-1272. PubMed ID: 32990234
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute exacerbation of liver-cirrhosis-associated portal vein thrombosis with direct-acting oral anticoagulant, edoxaban, used as an initial treatment in the early postoperative period after abdominal surgery: a case report.
Toyoda J; Morioka D; Horii N; Nakayama G; Oyama N; Asano F; Izumisawa Y; Miura M; Sato Y; Endo I
J Med Case Rep; 2021 Feb; 15(1):52. PubMed ID: 33563326
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.
Cui SB; Shu RH; Yan SP; Wu H; Chen Y; Wang L; Zhu Q
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):914-9. PubMed ID: 25856686
[TBL] [Abstract][Full Text] [Related]
13. Cirrhosis and COVID-19: Diffuse venous thrombosis and its clinical implication.
Canastar M; Okumura K; Bodin R; Gilet A; Dhand A
J Liver Transpl; 2022; 8():100105. PubMed ID: 38013900
[TBL] [Abstract][Full Text] [Related]
14. Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: Is it an Immuno-Inflammatory Disorder?
Abu El-Makarem MA; El-Akad AF; Elian MM; Sherif TM; El-Shaheed RA; Abd El Fatah AS; Sayed DM; Bakry RM; Mahmoud AM
Ann Hepatol; 2017; 16(4):574-583. PubMed ID: 28611261
[TBL] [Abstract][Full Text] [Related]
15. [Correlational study on portal vein thrombosis of liver cirrhosis].
Xu DQ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
[No Abstract] [Full Text] [Related]
16. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.
Gîrleanu I; Trifan A; Stanciu C; Sfarti C
World J Gastroenterol; 2018 Oct; 24(39):4419-4427. PubMed ID: 30356984
[TBL] [Abstract][Full Text] [Related]
17. Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.
Dong G; Huang XQ; Zhu YL; Ding H; Li F; Chen SY
Ann Transl Med; 2021 Feb; 9(4):289. PubMed ID: 33708916
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
[TBL] [Abstract][Full Text] [Related]
19. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]